Home › Groups › Cardiovascular Learning Network ›

News

  • Mortality Rates Are Greater in Women Admitted for MI without Chest Pain
    02/22/12
    In the February issue of the Journal of the American Medical Association, meta-analysis data indicate that there is a greater mortality risk for women admitted for myocardial infarction without the presence of chest pain. Watson Clinic and Lakeland Regional Medical Center researchers noted this difference when assessing over 1 million patients from the National Registry of Myocardial Infarction, comparing MI rates between sex, age, and presence of chest pain among documented cases from 1994 to 2006. Read More »
  • Mental State Linked to Physical Heart Health
    02/16/12
     Researchers from Tel Aviv University found that mental state, specifically depression, made heart attack patients more likely to be readmitted for cardiac events and chest pain. Read More »
  • BH4 Boosts Vascular Health in Postmenopausal Women
    02/15/12
     University of Colorado School of Medicine researchers found that in postmenopausal women, stiffening of arteries—which can increase the risk of stroke and heart disease—could be decreased with the introduction of tetrahydrobiopterin,  also referred to as BH4. Read More »
  • Using Heart-Derived Stem Cells to Rebuild Heart Tissue
    02/14/12
     In a clinical trial performed by the Cedars-Sinai Heart Institute, researchers found that performing a stem cell procedure using heart tissue from the patient reduced scarring and rebuilt heart tissue in the 12 months following a heart attack.  Read More »
  • Including Extra Tests Help Heart Failure Risk Stratification
    02/13/12
     Researchers from Emory University have found that taking echocardiographic variables and N-terminal pro B-type natriurectic peptide levels into consideration is more effective in stratifying heart failure risk than relying solely on clinical risk score in Medicare-eligible adults.  Read More »
  • Patients DRAGON Score Helps Predict Efficacy of tPA Therapies
    02/10/12
    According to a recent report in Neurology, a new patient assessment tool could allow physicians to determine which stroke patients may gain functional independence benefits from intravenous alteplase when the agent is administered within 4.5 hours of symptom onset. Read More »
  • Safety of Stem Cell Therapy for Stroke Patients Confirmed
    02/10/12
    At the American Stroke Association’s International Stroke Conference, 2 studies were presented examining the efficacy and safety of intravenous stem cell therapy to increase functionality in patients following stroke. Read More »
  • ICD Complications are More Prevalent in Women
    02/9/12
     Research presented in the current issue of Annals of Internal Medicine shows that women are not only more likely to have both early and late complications with implantable cardioverter-defibrillators than men, but also are less likely to receive appropriate shocks from these devices. Read More »
  • Anticoagulant Warfarin Does Not Surpass Aspirin in Stroke Prevention
    02/8/12
     Randomized trial results found the anticoagulant warfarin compared with aspirin cuts stroke and death risk by 7%; however, it also increases risk of intracranial, intracerebral, and gastrointestinal bleeding twice as much as aspirin. Read More »
  • Amniotic Fluid Stem Cells Reapplied to Create Infant Heart Tissue
    02/8/12
    Rice University and Texas Children’s Hospital researchers aim to patch infant heart tissue with stem cells obtained from amniotic fluid. Published results from the online journal Tissue Engineering Part A show that sloughed-off stem cells found in amniotic fluid may be able to be grown into usable patches, potentially helping nearly the nearly 32,000 infants born with congenital heart defects each year in the United States. Read More »
  • New Guidelines Rejects Aspirin for Thrombosis Prevention for Travelers
    02/7/12
     It was often suggested that aspirin be used to prevent deep-vein thrombosis for travelers on long flights, but according to new guidelines reported in CHEST, Gordon Guyatt, MD, of McMaster University in Ontario states that doctors should be urged to evaluate patient risk prior to recommending such prophylaxis. Read More »
  • Combining Clopidogrel with Aspirin May Heighten Risk of Bleeding and Death
    02/7/12
    New information was presented on the antiplatelet clopidogrel at the 2012 American Stroke Association's International Stroke Conference, stating that the addition of clopidogrel to an aspirin regimen may not help to prevent recurring strokes and may actually increase risk of bleeding and death in patients. Read More »
  • New Anticoagulant Helps Reduce Bleeding Stroke for AF Patients
    02/7/12
    At the 2012 American Stroke Association's International Stroke Conference, research was presented indicating that the anticoagulant rivaroxaban may help to reduce the risk of clot-related strokes in patients with atrial fibrillation (AF). Read More »
  • Stroke Score Results Suggest Possible Success with Intravenous Thrombolytic Therapy
    02/6/12
     Research released in the online edition of Stroke: Journal of the American Heart Association, presented new information on the application of Stroke iScore data. Investigators found that in patients with low to medium risk of death or disability, intravenous tissue plasminogen activator (tPA) further lowers the risk of these outcomes. In high-risk patients, use of tPA did not provide a significantly improved result. Read More »
  • New Transcatheter Aortic Valve Replacement Guidelines Issued
    02/3/12
     In response to the recent FDA approval of transcatheter aortic valve replacement (TAVR) in patients with aortic valvular stenosis, a number of noteworthy medical foundations and societies have collaborated to provide important steps and guidelines for the procedure. Read More »